Hemolytic transfusion reaction (HTR)
Not for Routine Use
When screening requests for approval, the following information may be taken into account as there is some evidence for IG to be considered as an option.
Order Number: H21-HTR
| Recommendations | IVIG may be considered as an option among supportive therapies for urgent situations in this disorder. |
| Dose/Frequency of Administration | Up to 2 g/kg divided over 2 to 5 consecutive days, short term up to 3 months |